Robin Foà, MD, Sapienza University of Rome, Rome, Italy, discusses how the COVID-19 pandemic has impacted the care of chronic lymphocytic leukemia (CLL) patients. From a survey conducted with the CAMPUS program, the results indicated that surprisingly few CLL patients were symptomatic and tested positive. However, the COVID-19 pandemic has had an impact on the management of disease as well. Treatment has been delayed or changed and clinical trial recruitment has been affected. This interview took place during the European Research Initiative on CLL (ERIC) International Virtual Meeting 2020.